Urinary tract infections: pathogenesis, host susceptibility and emerging therapeutics

Urinary tract infections (UTIs), which include any infection of the urethra, bladder or kidneys, account for an estimated 400 million infections and billions of dollars in health-care spending per year. The most common bacterium implicated in UTI is uropathogenic Escherichia coli , but diverse patho...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews. Microbiology 2025-02, Vol.23 (2), p.72-86
Hauptverfasser:	Timm, Morgan R., Russell, Seongmi K., Hultgren, Scott J.
Format:	Artikel
Sprache:	eng
Schlagworte:	631/250/255/1318 631/326/41/2531 631/326/41/2533 631/326/41/2534 692/4025/2768/1865 Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Antibiotics Antimicrobial resistance Bacteria - drug effects Bacteria - pathogenicity Biomedical and Life Sciences Coliforms Drug Resistance, Bacterial E coli Female Health services Host-Pathogen Interactions Humans Immunocompromised hosts Infectious Diseases Klebsiella Life Sciences Male Medical instruments Medical Microbiology Microbiology Parasitology Pathogenesis Pathogens Patients Prevention Review Article Susceptibility Urethra Urinary tract Urinary tract diseases Urinary tract infections Urinary Tract Infections - drug therapy Urinary Tract Infections - microbiology Urogenital system Virology Yeasts
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!